Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Hematology (blood)

  • News

    Blood group O linked to decreased risk of SARS-CoV-2 infection

    October 15, 2020

    A retrospective analysis of all Danish individuals with a known ABO blood group tested for SARS-CoV-2 showed a lower infection risk for SARS-CoV-2 infection in blood group O.

  • 1
    News

    INR fails to predict bleeding in patients with cirrhosis

    October 6, 2020

    The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.

  • 1
    News

    No rise in major hemorrhagic events with antiplatelet therapy after ICH

    August 3, 2020

    Does the risk of increased recurrent intracerebral hemorrhage (ICH) exceed the benefits of decreased vaso-occlusive events for patients resuming antiplatelet therapy following an ICH?

  • 1
    Opinion

    Hematologic manifestations of COVID-19

    July 29, 2020

    Dr. Alan P. Lyss examines a review on extrapulmonary manifestations of COVID-19, focusing in on hematologic effects.

  • 1
    Article

    Endothelial injury may play a major role in COVID-19–associated coagulopathy

    June 29, 2020

    Dr. Alan P. Lyss reviews research suggesting endotheliopathy may be a marker of COVID-19 severity.

  • News

    Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?

    May 26, 2020

    “The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available very rapidly.”

  • 1
    News

    Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit

    May 26, 2020

    Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.

  • 1
    News

    Inflammation, thrombosis biomarkers tied to COVID-19 deaths

    May 20, 2020

    “Of particular interest is the finding that over three quarters of critically ill patients required a ventilator and almost one third required renal dialysis support.”

  • 1
    News

    DOACs linked to lower fracture risk versus warfarin in AFib patients

    May 20, 2020

    The results suggest women may particularly benefit from DOAC use.

  • 1
    News

    COVID-19–associated coagulopathy

    May 7, 2020

    Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.

Previous1 … 4 5 6 7 8 … 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences